Asiatimes iconAsiatimesSep 8, 2026

Cheaper CAR-T therapy drawing global cancer patients to China

At 25, Michael Walters had already endured unsuccessful lymphoma treatments in New Zealand. He paid less than half that in Shanghai and learned on August 18 that his cancer was in complete remission.

Share this story

Send the public story page.

Useful takeaways from this story.

At 25, Michael Walters had already endured unsuccessful lymphoma treatments in New Zealand.

He paid less than half that in Shanghai and learned on August 18 that his cancer was in complete remission.

CAR-T, or chimeric antigen receptor T-cell therapy, re-engineers a patient's own immune […]

Building the complete brief

The page is ready to read now. The fuller skim-friendly version will appear here automatically.

The useful part

At 25, Michael Walters had already endured unsuccessful lymphoma treatments in New Zealand. He paid less than half that in Shanghai and learned on August 18 that his cancer was in complete remission. CAR-T, or chimeric antigen receptor T-cell therapy, re-engineers a patient's own immune […]

Details worth keeping

A Melbourne hospital quoted up to US$600,000 for CAR-T therapy.

Keep reading in the app

Open the app view to save this story, compare related coverage, and continue from the same source.

Open in app